文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

长链非编码 RNA GAS5 通过与 YAP 相互作用并触发其磷酸化和降解来抑制结直肠癌的进展,并且受到 mA 阅读器 YTHDF3 的负调控。

Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the mA reader YTHDF3.

机构信息

Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.

出版信息

Mol Cancer. 2019 Oct 16;18(1):143. doi: 10.1186/s12943-019-1079-y.


DOI:10.1186/s12943-019-1079-y
PMID:31619268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6794841/
Abstract

BACKGROUND: YAP activation is crucial for cancer development including colorectal cancer (CRC). Nevertheless, it remains unclear whether N6-Methyladenosine (mA) modified transcripts of long noncoding RNAs (lncRNAs) can regulate YAP activation in cancer progression. We investigated the functional link between lncRNAs and the mA modification in YAP signaling and CRC progression. METHODS: YAP interacting lncRNAs were screened by RIP-sequencing, RNA FISH and immunofluorescence co-staining assays. Interaction between YAP and lncRNA GAS5 was studied by biochemical methods. MeRIP-sequencing combined with lncRNA-sequencing were used to identify the mA modified targets of YTHDF3 in CRC. Gain-of-function and Loss-of-function analysis were performed to measure the function of GAS5-YAP-YTHDF3 axis in CRC progression in vitro and in vivo. RESULTS: GAS5 directly interacts with WW domain of YAP to facilitate translocation of endogenous YAP from the nucleus to the cytoplasm and promotes phosphorylation and subsequently ubiquitin-mediated degradation of YAP to inhibit CRC progression in vitro and in vivo. Notably, we demonstrate the mA reader YTHDF3 not only a novel target of YAP but also a key player in YAP signaling by facilitating mA-modified lncRNA GAS5 degradation, which profile a new insight into CRC progression. Clinically, lncRNA GAS5 expressions is negatively correlated with YAP and YTHDF3 protein levels in tumors from CRC patients. CONCLUSIONS: Our study uncovers a negative functional loop of lncRNA GAS5-YAP-YTHDF3 axis, and identifies a new mechanism for mA-induced decay of GAS5 on YAP signaling in progression of CRC which may offer a promising approach for CRC treatment.

摘要

背景:YAP 的激活对于癌症的发展至关重要,包括结直肠癌(CRC)。然而,目前尚不清楚长非编码 RNA(lncRNA)的 N6-甲基腺苷(mA)修饰转录本是否可以调节癌症进展中的 YAP 激活。我们研究了 lncRNA 与 YAP 信号和 CRC 进展中的 mA 修饰之间的功能联系。

方法:通过 RIP-seq、RNA FISH 和免疫荧光共染色检测筛选出与 YAP 相互作用的 lncRNA。通过生化方法研究 YAP 和 lncRNA GAS5 之间的相互作用。使用 MeRIP-seq 结合 lncRNA-seq 鉴定 YTHDF3 在 CRC 中 mA 修饰的靶标。进行功能获得和功能丧失分析,以测量 GAS5-YAP-YTHDF3 轴在 CRC 体外和体内进展中的功能。

结果:GAS5 直接与 YAP 的 WW 结构域相互作用,促进内源性 YAP 从核内到细胞质的易位,并促进 YAP 的磷酸化和随后的泛素介导的降解,从而抑制 CRC 的体外和体内进展。值得注意的是,我们证明 mA 阅读器 YTHDF3 不仅是 YAP 的一个新靶点,也是 YAP 信号的关键参与者,通过促进 mA 修饰的 lncRNA GAS5 降解,为 CRC 进展提供了新的见解。临床上,lncRNA GAS5 的表达与 CRC 患者肿瘤中的 YAP 和 YTHDF3 蛋白水平呈负相关。

结论:我们的研究揭示了 lncRNA GAS5-YAP-YTHDF3 轴的负功能循环,并确定了 mA 诱导的 GAS5 在 CRC 进展中对 YAP 信号的降解的新机制,这可能为 CRC 的治疗提供一种有前途的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/5035243d81fd/12943_2019_1079_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/f789755f436e/12943_2019_1079_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/76fbcd299e87/12943_2019_1079_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/8c66083c766b/12943_2019_1079_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/a2549eeb0d8c/12943_2019_1079_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/4f0f71b7f190/12943_2019_1079_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/cf1eefbf80bb/12943_2019_1079_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/5035243d81fd/12943_2019_1079_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/f789755f436e/12943_2019_1079_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/76fbcd299e87/12943_2019_1079_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/8c66083c766b/12943_2019_1079_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/a2549eeb0d8c/12943_2019_1079_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/4f0f71b7f190/12943_2019_1079_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/cf1eefbf80bb/12943_2019_1079_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87b/6794841/5035243d81fd/12943_2019_1079_Fig7_HTML.jpg

相似文献

[1]
Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the mA reader YTHDF3.

Mol Cancer. 2019-10-16

[2]
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.

Mol Cancer. 2019-12-2

[3]
Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing mA-mediated degradation of STEAP3 mRNA.

Mol Cancer. 2022-8-19

[4]
N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer.

J Hematol Oncol. 2021-11-7

[5]
lncRNA GAS5 inhibits colorectal cancer cell proliferation via the miR‑182‑5p/FOXO3a axis.

Oncol Rep. 2018-7-20

[6]
LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.

J Exp Clin Cancer Res. 2021-2-1

[7]
Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.

Cancer Biomark. 2018

[8]
lncRNA GAS5 inhibits malignant progression by regulating macroautophagy and forms a negative feedback regulatory loop with the miR‑34a/mTOR/SIRT1 pathway in colorectal cancer.

Oncol Rep. 2021-1

[9]
LncRNA GAS5 Interacts with MicroRNA-10b to Inhibit Cell Proliferation and Migration and Induces Apoptosis in Colorectal Cancer.

Comput Math Methods Med. 2022

[10]
Copy number amplification-induced overexpression of lncRNA LOC101927668 facilitates colorectal cancer progression by recruiting hnRNPD to disrupt RBM47/p53/p21 signaling.

J Exp Clin Cancer Res. 2024-9-30

引用本文的文献

[1]
Snhg18 regulates Yap subcellular localization to maintain bone homeostasis.

Nat Commun. 2025-8-14

[2]
The crosstalk of mA-modified RNA with DNA damage repair.

Trends Biochem Sci. 2025-7-21

[3]
Comprehensive analysis of m6A-related lncRNAs as prognosis factors in the immune microenvironment of colorectal cancer.

J Gastrointest Oncol. 2025-6-30

[4]
Hippo/YAP signaling pathway in colorectal cancer: regulatory mechanisms and potential drug exploration.

Front Oncol. 2025-6-19

[5]
Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potential.

Cell Oncol (Dordr). 2025-7-2

[6]
Unraveling LncRNA GAS5 in Atherosclerosis: Mechanistic Insights and Clinical Translation.

Biology (Basel). 2025-6-13

[7]
m6A reader IGF2BP2-stabilized lncRNA LHX1-DT inhibits renal cell carcinoma (RCC) cell proliferation and invasion by sponging miR-590-5p.

NPJ Precis Oncol. 2025-6-17

[8]
HGCMLDA: predicting lncRNA-disease associations using hypergraph contrastive learning and multi-scale attentional feature fusion.

Brief Bioinform. 2025-5-1

[9]
RNA epigenetic modifications as dynamic biomarkers in cancer: from mechanisms to clinical translation.

Biomark Res. 2025-6-7

[10]
YTHDF3 regulates IL32 mRNA stability to promote osteogenic differentiation of bone mesenchymal stem cells in ankylosing spondylitis.

J Transl Med. 2025-5-30

本文引用的文献

[1]
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.

Cancer Cell. 2018-12-10

[2]
CircFAT1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells.

Mol Cancer. 2018-12-4

[3]
The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ.

Nature. 2018-10-31

[4]
Genome-wide screening of NEAT1 regulators reveals cross-regulation between paraspeckles and mitochondria.

Nat Cell Biol. 2018-9-24

[5]
SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis.

Cancer Cell. 2018-6-28

[6]
YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity.

Cancer Discov. 2018-6-15

[7]
RNA N-methyladenosine modification in cancers: current status and perspectives.

Cell Res. 2018-4-23

[8]
N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential.

Nucleic Acids Res. 2018-5-4

[9]
Cancer statistics, 2018.

CA Cancer J Clin. 2018-1-4

[10]
Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.

Mol Cell. 2017-11-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索